These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. KCa channels as therapeutic targets in episodic ataxia type-2. Alviña K, Khodakhah K. J Neurosci; 2010 May 26; 30(21):7249-57. PubMed ID: 20505091 [Abstract] [Full Text] [Related]
8. Dramatically different levels of Cacna1a gene expression between pre-weaning wild type and leaner mice. Veneziano L, Albertosi S, Pesci D, Mantuano E, Frontali M, Jodice C. J Neurol Sci; 2011 Jun 15; 305(1-2):71-4. PubMed ID: 21440913 [Abstract] [Full Text] [Related]
9. Aberrant cerebellar Purkinje cell activity as the cause of motor attacks in a mouse model of episodic ataxia type 2. Tara E, Vitenzon A, Hess E, Khodakhah K. Dis Model Mech; 2018 Sep 21; 11(9):. PubMed ID: 30279196 [Abstract] [Full Text] [Related]
10. Epilepsy and episodic ataxia type 2: family study and review of the literature. Verriello L, Pauletto G, Nilo A, Lonigro I, Betto E, Valente M, Curcio F, Gigli GL. J Neurol; 2021 Nov 21; 268(11):4296-4302. PubMed ID: 33983550 [Abstract] [Full Text] [Related]
15. In vivo impact of presynaptic calcium channel dysfunction on motor axons in episodic ataxia type 2. Tomlinson SE, Tan SV, Burke D, Labrum RW, Haworth A, Gibbons VS, Sweeney MG, Griggs RC, Kullmann DM, Bostock H, Hanna MG. Brain; 2016 Feb 21; 139(Pt 2):380-91. PubMed ID: 26912519 [Abstract] [Full Text] [Related]
16. Missense CACNA1A mutation causing episodic ataxia type 2. Denier C, Ducros A, Durr A, Eymard B, Chassande B, Tournier-Lasserve E. Arch Neurol; 2001 Feb 21; 58(2):292-5. PubMed ID: 11176968 [Abstract] [Full Text] [Related]
18. Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission. Jen J, Wan J, Graves M, Yu H, Mock AF, Coulin CJ, Kim G, Yue Q, Papazian DM, Baloh RW. Neurology; 2001 Nov 27; 57(10):1843-8. PubMed ID: 11723274 [Abstract] [Full Text] [Related]